Oxford Bioscience Partners
Venture capital · Boston, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Atea Pharmaceuticals
5Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Atea Pharmaceuticals | Biotech | Public | May 29, 2020 | $155.9M |
| Shire Pharmaceuticals | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#88
Co-investors#198
Co-investors
- GenzymeVenture capital1 shared
- Novo HoldingsVenture capital1 shared
- RA CapitalVenture capital1 shared
- Santen PharmaceuticalVenture capital1 shared
- Third Rock VenturesVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.